Hepion Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HEPA and other ETFs, options, and stocks.

About HEPA

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. 

CEO
Robert T. Foster
CEORobert T. Foster
Employees
20
Employees20
Headquarters
Edison, New Jersey
HeadquartersEdison, New Jersey
Founded
2013
Founded2013
Employees
20
Employees20

HEPA Key Statistics

Market cap
39.55M
Market cap39.55M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
120.85K
Average volume120.85K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$1.60
52 Week high$1.60
52 Week low
$0.47
52 Week low$0.47

HEPA Earnings

-$0.26
-$0.17
-$0.08
$0.01
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, After Hours
ActualExpected Nov 14, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.